Paul K. Wotton

2010

In 2010, Paul K. Wotton earned a total compensation of $756.8K as Chief Executive Officer at Antares Pharma, a 19% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$160,000
Option Awards$116,526
Salary$390,000
Stock Awards$82,000
Other$8,250
Total$756,776

Wotton received $390K in salary, accounting for 52% of the total pay in 2010.

Wotton also received $160K in non-equity incentive plan, $116.5K in option awards, $82K in stock awards and $8.3K in other compensation.

Rankings

In 2010, Paul K. Wotton's compensation ranked 6,284th out of 10,439 executives tracked by ExecPay. In other words, Wotton earned more than 39.8% of executives.

ClassificationRankingPercentile
All
6,284
out of 10,439
40th
Division
Manufacturing
2,270
out of 3,838
41st
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
342
out of 672
49th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
171
out of 378
55th
Industry
Surgical and Medical Instruments and Apparatus
96
out of 245
61st
Source: SEC filing on April 12, 2013.

Wotton's colleagues

We found three more compensation records of executives who worked with Paul K. Wotton at Antares Pharma in 2010.

2010

Robert Apple

Antares Pharma

Chief Financial Officer

2010

Dario Carrara

Antares Pharma

Managing Director, Pharmaceutical Group

2010

Peter Sadowski

Antares Pharma

Chief Technology Officer

You may also like